Using Adenovirus to Enhance Cancer Treatment with TRAIL
Author Information
Author(s): Abou El Hassan M A I, Mastenbroek D C J, Gerritsen W R, Giaccone G, Kruyt F A E
Primary Institution: VU University Medical Centre, Amsterdam, The Netherlands
Hypothesis
Can adenoviral expression of full-length TRAIL enhance the effectiveness of chemotherapy and radiotherapy in treating non-small-cell lung cancer (NSCLC)?
Conclusion
Adenoviral expression of full-length TRAIL combined with chemotherapy or radiotherapy may provide an effective and selective strategy for treating NSCLC.
Supporting Evidence
- Adenoviral expression of TRAIL effectively killed NSCLC cells in a dose-dependent manner.
- Combination treatment with chemotherapy significantly enhanced TRAIL-induced apoptosis.
- Bcl2 overexpression protected cells from TRAIL-induced apoptosis.
Takeaway
This study shows that a special virus can help cancer treatments work better by making cancer cells die more easily.
Methodology
The study involved culturing NSCLC cells and normal cells, infecting them with an adenoviral vector expressing TRAIL, and measuring cell viability and apoptosis through various assays.
Limitations
The study primarily focused on one cell line and may not fully represent the complexity of NSCLC in patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website